Five years ago, U.S. pharmaceutical companies didn’t license any new drugs from China. By 2024, one-third of their new compounds were coming from Chinese biotechnology firms. Why are U.S. drugmakers ...

In this interview, Dr. Malika Bsibsi discusses the role of iPSC models in advancing neuroscience drug discovery, focusing on neurodegeneration, neuroinflammation, and innovative in vitro approaches.

Artificial intelligence and machine learning are being embedded in every aspect of the drug discovery and development process. In the preclinical stages, for example, companies are using advanced AI ...

Recursion Pharmaceuticals ( RXRX +1.91%) was in the headlines on Monday, and for the right reason. One of the biotech company ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

In the face of US federal funding cuts, biomedical researchers propose strategies for continued progress in drug discovery.

More than two decades ago, physicists-by-training Colin Hill and Iya Khalil, PhD, co-founded Gene Network Sciences (GNS), a biosimulation company based in Somerville, MA, on the back of the Human ...

Intellicule, a software company whose solutions determine the 3D structures of biomolecules imaged with cryogenic-electron microscopy (cryo-EM), has received a $217,941 Small Business Innovation ...

Big investments in artificial intelligence (AI) don’t guarantee big wins. This point was emphasized by Niven R. Narain, the president and CEO of BPGbio president and CEO Niven R. Narain, PhD, in an ...

A novel gut-restricted and PHD specific Inhibitor designed and optimized with the support of Insilico’s Chemistry42 commercially-available generative reinforcement learning platform, for Inflammatory ...